ClinicalTrials.gov
public full text
Public Domain
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
The purpose of the study is to investigate the drug octreotide acetate in a new intranasal formulation and compare it to the FDA-approved subcutaneous (SC) injection formulation. The two octreotide acetate formulations will be evaluated following separate administrations for safety and tolerability including any side effects, the speed at which the drug is absorbed and eliminated in the body, and the ability of the drug to lower the levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy#864073
- Octreotide in Severe Polycystic Liver Disease#859653
- Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers#813602
- A Single-dose Study of Octreotide Injection in Healthy Adult Subjects#825700
- Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly#883856
Record · ID 867606
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive